Pharma Foods International Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Yongsook Kim

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	25yrs
Participación del CEO	13.1%
Permanencia media de la dirección	4.7yrs
Promedio de permanencia en la Junta Directiva	9.1yrs

Actualizaciones recientes de la dirección

Recent updates

Pharma Foods International Co., Ltd.'s (TSE:2929) Prospects Need A Boost To Lift Shares

Oct 31

We Think Pharma Foods International's (TSE:2929) Solid Earnings Are Understated

Sep 22

Is Pharma Foods International (TSE:2929) Using Too Much Debt?

Jul 23

We Like Pharma Foods International's (TSE:2929) Earnings For More Than Just Statutory Profit

Mar 23

CEO

Yongsook Kim (77 yo)

25yrs

Permanencia

Mr. Mu Jo Kim, also known as Yongsook, is the Chief Executive Officer of Pharma Foods International Co., Ltd. He has been the President of Pharma Foods International Co., Ltd. since November 1999 and serve...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Mu Jo Kim	CEO, President & Director	25yrs	sin datos	13.09% ¥ 3.5b
Noriko Horie	Head Office Sales Person & Director	no data	sin datos	0.31% ¥ 82.4m
Kazuyuki Masuda	Senior MD	8.3yrs	sin datos	2.55% ¥ 680.9m
Yasunori Inoue	MD, Tokyo Sales Representative & Director	no data	sin datos	0.088% ¥ 23.4m
Yong-il Kim	GM of Development Department & Director	1.1yrs	sin datos	sin datos
Hirotaka Higashiyama	In Charge of Management Department & Director	1.1yrs	sin datos	0.0092% ¥ 2.5m

4.7yrs

Permanencia media

48.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 2929 se considera experimentado (4.7 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Mu Jo Kim	CEO, President & Director	no data	sin datos	13.09% ¥ 3.5b
Noriko Horie	Head Office Sales Person & Director	13.4yrs	sin datos	0.31% ¥ 82.4m
Kazuyuki Masuda	Senior MD	16.1yrs	sin datos	2.55% ¥ 680.9m
Yasunori Inoue	MD, Tokyo Sales Representative & Director	5.1yrs	sin datos	0.088% ¥ 23.4m
Yong-il Kim	GM of Development Department & Director	1.1yrs	sin datos	sin datos
Hirotaka Higashiyama	In Charge of Management Department & Director	1.1yrs	sin datos	0.0092% ¥ 2.5m
Nobuo Hatta	External Auditor	11.1yrs	sin datos	0.026% ¥ 6.9m
Shinya Samura	Outside Independent Director	9.1yrs	sin datos	0.068% ¥ 18.1m
Takashi Iino	Head of Audit & Supervisory Board	15.1yrs	sin datos	0.072% ¥ 19.2m
Shinya Tsujimoto	External Auditor	14.1yrs	sin datos	0.037% ¥ 10.0m
Tetsuro Yamane	Outside Independent Director	6.1yrs	sin datos	sin datos
Taro Ueda	Outside Independent Director	3.1yrs	sin datos	sin datos

9.1yrs

Permanencia media

66yo

Promedio de edad

Junta con experiencia: La junta directiva de 2929 se considera experimentada (9.1 años de antigüedad promedio).

Pharma Foods International Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Pharma Foods International Co., Ltd., Annual General Meeting, Oct 24, 2024

Pharma Foods International Co., Ltd., Annual General Meeting, Oct 25, 2023

No independent directors

No independent directors

Recent updates

New minor risk - Share price stability

Pharma Foods International Co., Ltd. announced that it has received ¥761.6052 million in funding from ITOCHU Corporation

Final dividend of JP¥12.50 announced

Pharma Foods International Co., Ltd.'s (TSE:2929) Prospects Need A Boost To Lift Shares

Pharma Foods International Co., Ltd. to Report Q1, 2025 Results on Dec 11, 2024

Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending July 31, 2025

We Think Pharma Foods International's (TSE:2929) Solid Earnings Are Understated

Full year 2024 earnings released: EPS: JP¥113 (vs JP¥107 in FY 2023)

Pharma Foods International Co., Ltd., Annual General Meeting, Oct 24, 2024

Investor sentiment deteriorates as stock falls 25%

Pharma Foods International Co., Ltd. to Report Fiscal Year 2024 Results on Sep 12, 2024

Is Pharma Foods International (TSE:2929) Using Too Much Debt?

Upcoming dividend of JP¥10.00 per share

Third quarter 2024 earnings released: EPS: JP¥38.74 (vs JP¥68.72 in 3Q 2023)

Pharma Foods International Co., Ltd. to Report Q3, 2024 Results on Jun 10, 2024

We Like Pharma Foods International's (TSE:2929) Earnings For More Than Just Statutory Profit

Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending July 31, 2024

Second quarter 2024 earnings released: EPS: JP¥16.76 (vs JP¥31.44 in 2Q 2023)

Pharma Foods International Co., Ltd. to Report Q2, 2024 Results on Mar 11, 2024

Upcoming dividend of JP¥10.00 per share at 1.9% yield

Investor sentiment improves as stock rises 15%

First quarter 2024 earnings released: EPS: JP¥9.92 (vs JP¥62.76 loss in 1Q 2023)

Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending July 31, 2024

New minor risk - Dividend sustainability

Pharma Foods International Co., Ltd. to Report Q1, 2024 Results on Dec 11, 2023

Pharma Foods International Co., Ltd. (TSE:2929) agreed to acquire Healthcare Mail Order Business Of Daicel from Daicel Corporation (TSE:4202).

Pharma Foods International Co., Ltd., Annual General Meeting, Oct 25, 2023

Full year 2023 earnings released: EPS: JP¥107 (vs JP¥12.89 loss in FY 2022)

Pharma Foods International Co., Ltd. to Report Fiscal Year 2023 Results on Sep 11, 2023

Upcoming dividend of JP¥12.00 per share at 1.2% yield

Third quarter 2023 earnings released: EPS: JP¥68.72 (vs JP¥63.54 loss in 3Q 2022)

Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending July 31, 2023

Second quarter 2023 earnings released: EPS: JP¥31.44 (vs JP¥11.38 in 2Q 2022)

Pharma Foods International Co., Ltd. to Report Q2, 2023 Results on Mar 07, 2023

Upcoming dividend of JP¥10.00 per share

First quarter 2023 earnings released: JP¥62.76 loss per share (vs JP¥42.44 profit in 1Q 2022)

Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending July 31, 2023

No independent directors

Pharma Foods International Co., Ltd. to Report Q1, 2023 Results on Dec 05, 2022

Pharma Foods International Co., Ltd. (TSE:2929) announces an Equity Buyback for 270,000 shares, representing 0.93% for ¥300 million.

Full year 2022 earnings released: JP¥12.89 loss per share (vs JP¥132 profit in FY 2021)

Pharma Foods International Co., Ltd. Declares Dividend for the Year Ended July 30, 2022, Payable on October 21, 2022

Pharma Foods International Co., Ltd. to Report Fiscal Year 2022 Results on Sep 06, 2022

Upcoming dividend of JP¥10.00 per share

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: JP¥63.59 loss per share (vs JP¥68.78 profit in 3Q 2021)

Pharma Foods International Co., Ltd. to Report Q3, 2022 Results on Jun 03, 2022

No independent directors

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of JP¥10.00 per share

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: EPS JP¥132 (vs JP¥23.76 in FY 2020)

Pharma Foods International Co., Ltd. (TSE:2929) announces an Equity Buyback for 120,000 shares, representing 0.41% for ¥300 million.

Pharma Foods International Co., Ltd. (TSE:2929) completed the acquisition of unknown majority stake in Meiji Yakuhin Co.Ltd. from Toshimitsu Ishizaka and others.

Investor sentiment improved over the past week

Pharma Foods International Co., Ltd. (TSE:2929) agreed to acquire unknown majority stake in Meiji Yakuhin Co.Ltd. from Toshimitsu Ishizaka and others.

Upcoming dividend of JP¥10.00 per share

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS JP¥68.78 (vs JP¥46.21 in 3Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS JP¥33.77 (vs JP¥25.97 loss in 2Q 2020)

New 90-day high: JP¥3,400

Pharma Foods International Co., Ltd. Enters into Exclusive Licensing Agreement with Mitsubishi Tanabe Pharma Corporation for A New Therapeutic Antibody to Treat Autoimmune Diseases

Upcoming Dividend of JP¥5.00 Per Share

Pharma Foods International Co., Ltd. to Report Q2, 2021 Results on Mar 05, 2021

First quarter 2021 earnings released: JP¥49.14 loss per share

First quarter 2021 earnings released: JP¥49.14 loss per share

Pharma Foods International Co., Ltd. to Report Fiscal Year 2020 Results on Sep 07, 2020